The current NBY market cap is 2.84M. The company's latest EPS is USD -3.4175 and P/E is -0.17.
Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Revenue | 3.27M | 3.73M | 2.63M | 2.4M | 2.44M |
Operating Income | -1.12M | -3.39M | -2.44M | -1.05M | -1.06M |
Net Income | -1.76M | -9.17M | -3.59M | -1.59M | -2.22M |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Revenue | 6.6M | 9.93M | 8.42M | 14.4M | 14.73M |
Operating Income | -9.4M | -6.43M | -8.86M | -14.42M | -7.6M |
Net Income | -10.46M | -11.04M | -6.56M | -16.27M | -16.7M |
Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Assets | 12.85M | 9.03M | 5.36M | 3.93M | 3.88M |
Total Liabilities | 5.82M | 5.72M | 5.2M | 4.54M | 2.81M |
Total Equity | 7.04M | 3.31M | 160k | -617k | 1.07M |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Assets | 11.22M | 15.24M | 23.98M | 16.4M | 9.03M |
Total Liabilities | 10.25M | 2.92M | 13.81M | 5.85M | 5.72M |
Total Equity | 973k | 12.32M | 10.17M | 10.55M | 3.31M |
Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Operating | -3.82M | -4.13M | -1.57M | -2.15M | -4.37M |
Investing | -17k | -19k | 1.07M | 1.07M | 1.02M |
Financing | 1.94M | 1.91M | -597k | -1.09M | 1M |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Operating | -7.93M | -4.72M | -9.19M | -6.65M | -4.13M |
Investing | -19k | -26k | -12.05M | -112k | -19k |
Financing | 11.7M | 9.76M | 16.79M | 4.63M | 1.91M |
Market Cap | 2.84M |
Price to Earnings Ratio | -0.17 |
Price to Sales Ratio | 0.2 |
Price to Cash Ratio | 0.92 |
Price to Book Ratio | 0.87 |
Dividend Yield | - |
Shares Outstanding | 4.89M |
Average Volume (1 week) | 56.56k |
Average Volume (1 Month) | 89.35k |
52 Week Change | -94.32% |
52 Week High | 10.234 |
52 Week Low | 0.3611 |
Spread (Intraday) | 0.02 (3.32%) |
Company Name | NovaBay Pharmaceuticals Inc New |
Address |
1209 orange street wilmington, delaware 19801 |
Website | https://www.novabay.com |
Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.